Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Return on Equity (2016 - 2026)

Champions Oncology has reported Return on Equity over the past 16 years, most recently at 0.01% for Q1 2026.

  • For Q1 2026, Return on Equity fell 3.0% year-over-year to 0.01%; the TTM value through Jan 2026 reached 0.01%, down 3.0%, while the annual FY2025 figure was 0.05%, 10.0% up from the prior year.
  • Return on Equity for Q1 2026 was 0.01% at Champions Oncology, down from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.1% in Q1 2024 and troughed at 0.1% in Q4 2023.
  • A 5-year average of 0.0% and a median of 0.0% in 2022 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: decreased -10bps in 2023 and later rose 10bps in 2024.
  • Year by year, Return on Equity stood at 0.0% in 2022, then crashed by -81262bps to 0.1% in 2023, then surged by 65bps to 0.03% in 2024, then soared by 118bps to 0.01% in 2025, then crashed by -188bps to 0.01% in 2026.
  • Business Quant data shows Return on Equity for CSBR at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.